Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 1.890
0.00 (0.00%)
Jun 23, 2026, 3:51 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €300.63 thousand as of June 24, 2026. Its market cap has decreased by -49.89% in one year.
Market Cap
300.63K
Enterprise Value
432.78K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.89
Market Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 300.63K, a decrease of -49.89%. That is a compound annual growth rate of -47.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 300.63K | 7,252.19% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advicenne | 15.83M |
| Aelis Farma | 13.60M |
| Poxel | 11.18M |
| NFL Biosciences | 10.39M |
| Aton | 9.44M |
| TME Pharma | 6.90M |
| Oncodesign Precision Medicine Société anonyme | 6.68M |
| Plant Advanced Technologies | 6.06M |